Aurorite (605116.SH) passes the drug GMP compliance inspection.

Financial APP news, Aotec (605116.SH) announced that recently, the company received the "Drug GMP Compliance Inspection Notice" (Zhe 2025 No. 0267, Zhe 2025 No. 0268) issued by the Zhejiang Provincial Drug Administration. The inspection scope and related workshops and production lines are as follows: 1. Active pharmaceutical ingredient (Mometasone furoate): workshop 806, workshop 863, production line A3; 2. Active pharmaceutical ingredient (Betamethasone): workshop 802, production line BETB.